Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. uri icon

authors

  • Falsey, Ann R
  • Mulligan, Mark J
  • McEvoy, Charlene
  • DeJesus, Edwin
  • Hassman, Michael
  • Little, Susan J
  • Pahud, Barbara A
  • Durbin, Anna
  • Pickrell, Paul
  • Daar, Eric S
  • Bush, Larry
  • Sobieszczyk, Magdalena E
  • Solis, Joel
  • Carr, Quito Osuna
  • Oyedele, Temitope
  • Buchbinder, Susan
  • Cowden, Jessica
  • Vargas, Sergio L
  • Guerreros Benavides, Alfredo
  • Call, Robert
  • Keefer, Michael C
  • Kirkpatrick, Beth D
  • Hirsch, Ian
  • Pullman, John
  • Tong, Tina
  • Brewinski Isaacs, Margaret
  • Benkeser, David
  • Janes, Holly E
  • Nason, Martha C
  • Green, Justin A
  • Kelly, Elizabeth J
  • Maaske, Jill
  • Mueller, Nancy
  • Sproule, Stephanie
  • Shoemaker, Kathryn
  • Takas, Therese
  • Marshall, Richard P
  • Pangalos, Menelas N
  • Villafana, Tonya
  • Gonzalez-Lopez, Antonio
  • Robb, Merlin L
  • Corey, Lawrence
  • Neuzil, Kathleen M
  • Hahn, William
  • Hunt, Julie

publication date

  • January 1, 2021